{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T15:08:54Z","timestamp":1754147334631,"version":"3.41.2"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s529788","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:00:20Z","timestamp":1752843620000},"page":"495-505","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed\/Refractory Multiple Myeloma: Real World Evidence from Italy"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Valentina","family":"Perrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2092-4638","authenticated-orcid":true,"given":"Melania","family":"Leogrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-9532","authenticated-orcid":true,"given":"Maria","family":"Cappuccilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-6659","authenticated-orcid":true,"given":"Luca","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"},{"key":"ref2","first-page":"3","volume":"9","author":"Padala","year":"2021","journal-title":"Med Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"Huang","year":"2022","journal-title":"Lancet Haematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.hoc.2007.08.008","volume":"21","author":"Rajkumar","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood-2006-04-015909","volume":"108","author":"Richardson","year":"2006","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4065\/79.7.867","volume":"79","author":"Kumar","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/leu.2017.138","volume":"31","author":"Kumar","year":"2017","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2052658","DOI":"10.1080\/21645515.2022.2052658","volume":"18","author":"Gozzetti","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e810\u2013e821.","DOI":"10.1016\/S2352-3026(22)00263-0","volume":"9","author":"Goldschmidt","year":"2022","journal-title":"Lancet Haematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17474086.2017.1285694","volume":"10","author":"Boudreault","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/17474086.2016.1127754","volume":"9","author":"Pantani","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"844779","DOI":"10.3389\/fonc.2022.844779","volume":"12","author":"Bertamini","year":"2022","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2019.09.625","volume":"20","author":"Chari","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref15","unstructured":"Italian Medicines Agency (AIFA): determina 24 marzo 2022: regime di rimborsabilit\u00e0 e prezzo, a seguito di nuove indicazioni terapeutiche, del medicinale per uso umano \u00abSarclisa\u00bb. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2022\/04\/04\/22A02091\/sg. Accessed February 20, 2024."},{"key":"ref16","unstructured":"Italian Medicines Agency (AIFA): determina 19 febbraio 2019. Riclassificazione del medicinale per uso umano \u00abNinlaro\u00bb. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/847786\/NINLARO_GU_n.57_8-3-2019.pdf. Accessed February 20, 2024."},{"key":"ref17","unstructured":"Italian Medicines Agency (AIFA): determina 9 settembre 2021. Riclassificazione del medicinale per uso umano \u00abSarclisa\u00bb. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/847786\/determina_Sarclisa_GUn.226.pdf. Accessed February, 20, 2024."},{"key":"ref18","unstructured":"Italian Medicines Agency (AIFA): determina 13 gennaio 2023. Regime di rimborsabilit\u00e0\u2019 e prezzo, a seguito di nuove indicazioni terapeutiche, del medicinale per uso umano \u00abDarzalex\u00bb. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/961234\/Determina_24-2023_Darzalex.pdf. Accessed February 20, 2024."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/bcj.2011.34","volume":"1","author":"Kleber","year":"2011","journal-title":"Blood Cancer J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25764","volume":"95","author":"Chakraborty","year":"2020","journal-title":"Am J Hematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2196\/49861","author":"Nourallah","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"ref24","first-page":"1818","volume":"130","author":"Chari","year":"2017","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s41669-022-00344-4","volume":"6","author":"Kocaata","year":"2022","journal-title":"Pharmacoecon Open"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40487-022-00198-0","volume":"10","author":"Jagannath","year":"2022","journal-title":"Oncol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.2217\/fon-2022-0846","volume":"18","author":"Iida","year":"2022","journal-title":"Future Oncol"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/104964","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/104964","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:00:23Z","timestamp":1752843623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/healthcare-costs-and-treatment-patterns-of-triplet-therapies-in-relaps-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2147\/ceor.s529788","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}